Two Strengths
Available in 90 mcg and 180 mcg dry powder inhaler.
For U.S. Healthcare Professionals
A Maintenance Treatment Option for Appropriate Patients With Asthma.
PULMICORT FLEXHALER® (budesonide inhalation powder) is indicated for the maintenance treatment of asthma as prophylactic therapy in adult and pediatric patients 6 years of age or older.
Limitation of Use: Not indicated for the relief of acute bronchospasm.
At a Glance
Key facts for your clinical review
Age 6 and Older
Maintenance treatment of asthma in adult and pediatric patients 6 years of age or older.
Dry Powder Inhaler
A breath-actuated dry powder inhaler delivering budesonide inhalation powder.
Inhaled Maintenance Therapy
Delivered via dry powder inhaler for daily prophylactic use.
Strength
90 mcg
Strength
180 mcg
Product Information
PULMICORT FLEXHALER® (budesonide inhalation powder)
Indication
PULMICORT FLEXHALER® (budesonide inhalation powder) is indicated for the maintenance treatment of asthma as prophylactic therapy in adult and pediatric patients 6 years of age or older.
Limitation of Use
Not indicated for the relief of acute bronchospasm.
Formulation
Budesonide inhalation powder delivered via a dry powder inhaler, available in 90 mcg and 180 mcg strengths.
For dosing, administration, contraindications, warnings, and full clinical information, please refer to the Full Prescribing Information.
Read Full Prescribing InformationHow to Use
Four steps to review with your patients
A high-level summary of key patient-use steps. For the complete procedure, always refer to the official Instructions for Use.
- 01
Prime before first use
Prime the inhaler before the first dose as described in the Instructions for Use. Priming is not required for subsequent doses.
- 02
Load the dose
Hold the inhaler upright and load by twisting the grip until it clicks to prepare the next dose.
- 03
Inhale deeply and forcefully
Place the mouthpiece between the lips and inhale deeply and forcefully through the mouthpiece.
- 04
Rinse mouth — do not swallow
After each dose, rinse the mouth with water and spit. Do not swallow the rinse water.
Important Safety Information
PULMICORT FLEXHALER® Safety
Indication
PULMICORT FLEXHALER® (budesonide inhalation powder) is indicated for the maintenance treatment of asthma as prophylactic therapy in adult and pediatric patients 6 years of age or older.
Limitation of Use
Not indicated for the relief of acute bronchospasm.
This is a summary of Important Safety Information. Please see the Full Prescribing Information for complete details, including additional Warnings and Precautions, Contraindications, and Adverse Reactions.
Ask About Pulmicort
Guided product assistant
A deterministic assistant that answers from approved PULMICORT FLEXHALER® source content. Every response includes a source link.
Responses are limited to approved product information and are not medical advice. To report a suspected adverse reaction, contact Allegis Pharmaceuticals Drug Safety at 1-888-825-3594 or the FDA MedWatch program.
Pulmicort Product Assistant
Deterministic · Approved sources only
Hello. I can share approved information about PULMICORT FLEXHALER® from the Prescribing Information, Instructions for Use, and the official product website. Choose a question below or type your own. I do not provide medical advice.
Resources
Approved reference materials
All links open the official source in a new tab.
Prescribing Information
Complete PULMICORT FLEXHALER® Prescribing Information (PDF).
Instructions for Use
Official patient Instructions for Use (PDF).
Official Product Website
Visit pulmicortflexhaler.com for the official product site.
FDA MedWatch
Report suspected adverse events to the FDA MedWatch program.
Contact
Allegis Pharmaceuticals
For general product inquiries related to PULMICORT FLEXHALER®, please contact Allegis Pharmaceuticals.
Reporting a Suspected Adverse Reaction
Suspected adverse reactions should not be sent to the general sales inbox. Please report them directly to Allegis Pharmaceuticals Drug Safety or the FDA MedWatch program.